Australia's most trusted
source of pharma news
Friday, 18 October 2024
Posted 17 October 2024 PM
Celosia Therapeutics CEO Kathryn Sunn has been crowned the Research Commercialisation Professional of the Year at the 2024 Knowledge Commercialisation Australasia (KCA) Awards.
Sunn has over 20 years of experience in intellectual property and commercial law and has held leadership roles at Macquarie University, the University of Melbourne, and the University of Sydney.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.